Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PACS
PACS logo

PACS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Pacs Group Inc (PACS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
35.050
1 Day change
0.14%
52 Week Range
43.080
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Pacs Group Inc (PACS) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has strong financial performance, positive analyst sentiment, and bullish technical indicators, making it a solid choice for long-term growth.

Technical Analysis

The MACD is positive and contracting, indicating a bullish trend. RSI is neutral at 55.11, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above key support levels, with a pivot at 33.652 and resistance at 36.024.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment in the options market.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
5

Positive Catalysts

  • Strong Q4 financials with revenue up 12.43% YoY, net income up 60.48% YoY, and EPS up 58.33% YoY. Analysts have raised price targets recently, with UBS, Oppenheimer, and RBC Capital maintaining Buy or Outperform ratings. The company is expected to gain operational momentum in 2026.

Neutral/Negative Catalysts

  • Recent selloff due to perceived organic growth concerns and acquisition-related dilution, although analysts believe the selloff may be overdone.

Financial Performance

In Q4 2025, revenue increased to $1.36 billion (+12.43% YoY), net income grew to $59.7 million (+60.48% YoY), EPS rose to 0.38 (+58.33% YoY), and gross margin improved to 15.33% (+14.57% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are bullish, with recent price target increases from UBS ($44), Oppenheimer ($42), and RBC Capital ($52). All maintain Buy or Outperform ratings, citing strong financial performance and operational momentum.

Wall Street analysts forecast PACS stock price to rise
5 Analyst Rating
Wall Street analysts forecast PACS stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 35.050
sliders
Low
40
Averages
42.6
High
47
Current: 35.050
sliders
Low
40
Averages
42.6
High
47
UBS
NULL -> Buy
maintain
$42 -> $44
AI Analysis
2026-03-04
Reason
UBS
Price Target
$42 -> $44
AI Analysis
2026-03-04
maintain
NULL -> Buy
Reason
UBS raised the firm's price target on Pacs Group to $44 from $42 and keeps a Buy rating on the shares.
Oppenheimer
Oppenheimer
Outperform
maintain
$40 -> $42
2026-03-04
Reason
Oppenheimer
Oppenheimer
Price Target
$40 -> $42
2026-03-04
maintain
Outperform
Reason
Oppenheimer raised the firm's price target on Pacs Group to $42 from $40 and keeps an Outperform rating on the shares following the company's Q4 results and 10-K. Following its internal investigation and related reporting delays, Pacs Group is looking to gain operational momentum in 2026, the firm notes.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PACS
Unlock Now

People Also Watch